DOD Ovarian Cancer Pilot Award

archived

The OCRP Pilot Award supports the exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. The proposed research must demonstrate a clear focus on ovarian cancer (e.g., using tissues, cell lines, datasets, or appropriate animal models), and serve as a catalyst to expand or modify current thinking about and/or approaches in ovarian cancer. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s). To foster research with potential to yield new avenues of investigation, preliminary data are not required, but are allowed. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale; however, applications that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the Pilot Award. The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects. Clinical trials will not be supported by this award mechanism. Innovation: Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or provide new insights, technologies, or applications that have the potential to meet the OCRP mission. The following list, although not all-inclusive, provides examples of research that are not considered innovative and will likely not be considered for funding under this award mechanism: • Investigating the next logical step or continuation of a previous research project. • Proposing work that is an incremental advancement of published data. • Using a published series of in vitro assays to further characterize a model system. • Incorporating known biomarkers into in vivo or clinical models of ovarian cancer.

High